MX2016005613A - Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. - Google Patents
Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos.Info
- Publication number
- MX2016005613A MX2016005613A MX2016005613A MX2016005613A MX2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A
- Authority
- MX
- Mexico
- Prior art keywords
- citrus greening
- pathogenesis
- blight
- treatment methods
- pathogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a un modelo de patogénesis novedoso, método o kit para detectar la patogénesis en un sujeto. En particular, la invención proporciona un índice patógeno obtenido de una relación de la cantidad de dianas de patógeno dual con respecto a la cantidad de medidas cuantitativas de hospedador. El índice patógeno se usa en el diagnóstico, el pronóstico y/o la estrategia de tratamiento de cualquier enfermedad, que incluye las enfermedades de enverdecimiento de los cítricos (HLB). También se proporcionan herramientas de investigación y métodos para el análisis de fármacos para el tratamiento o la prevención de enfermedades de enverdecimiento de los cítricos, así como métodos de tratamiento o prevención de enfermedades de enverdecimiento de los cítricos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361897626P | 2013-10-30 | 2013-10-30 | |
PCT/US2014/063181 WO2015066341A2 (en) | 2013-10-30 | 2014-10-30 | Pathogenesis quantification systems and treatment methods for citrus greening blight |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016005613A true MX2016005613A (es) | 2016-12-20 |
MX367192B MX367192B (es) | 2019-08-08 |
Family
ID=53005380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016005613A MX367192B (es) | 2013-10-30 | 2014-10-30 | Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. |
Country Status (6)
Country | Link |
---|---|
US (2) | US10351918B2 (es) |
EP (1) | EP3063272A2 (es) |
JP (1) | JP2016538882A (es) |
CN (1) | CN105722977A (es) |
MX (1) | MX367192B (es) |
WO (1) | WO2015066341A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX367192B (es) | 2013-10-30 | 2019-08-08 | Green Life Biotech Llc | Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. |
US10501814B2 (en) * | 2015-12-28 | 2019-12-10 | PathogenDX Inc | Microarray based multiplex pathogen analysis and uses thereof |
US10612075B2 (en) * | 2015-12-28 | 2020-04-07 | PathogenDX Inc | Microarray based multiplex pathogen analysis and uses thereof |
US10513745B2 (en) * | 2015-12-28 | 2019-12-24 | PathogenDX Inc | Microarray based multiplex pathogen analysis and uses thereof |
US20190137476A1 (en) * | 2016-03-25 | 2019-05-09 | The Regents Of The University Of California | Detecting huanglongbing (hlb) in citrus plants by analyzing changes in emitted volatile organic compounds |
DE102016207147A1 (de) * | 2016-04-27 | 2017-11-02 | Nordkorn Saaten Gmbh | Verfahren zum Nachweis von biologisch aktiven Pflanzenpathogenen |
CN106929584A (zh) * | 2017-03-30 | 2017-07-07 | 上海市农业科学院 | 一种检测Camv35S启动子的RPA引物、试剂盒及检测方法 |
WO2020102537A1 (en) * | 2018-11-14 | 2020-05-22 | Washington State University | Host-free 'candidatus liberibacter asiaticus' culture |
CN114829882B (zh) | 2019-11-05 | 2023-02-28 | 阿比尔技术公司 | 植物产品中感染的预测 |
CN116018144A (zh) * | 2020-06-15 | 2023-04-25 | 玛希敦大学 | 一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物 |
CN111944919B (zh) * | 2020-07-31 | 2023-05-26 | 广东省农业科学院果树研究所 | 一种可以在田间、常温操作的香蕉枯萎病菌热带4号小种可视化检测技术体系 |
CN112280879A (zh) * | 2020-11-17 | 2021-01-29 | 广东省农业科学院植物保护研究所 | 一种快速检测柑橘黄龙病亚洲种的rpa引物、试剂盒及其检测方法与应用 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
DE3529478A1 (de) | 1985-08-16 | 1987-02-19 | Boehringer Mannheim Gmbh | 7-desaza-2'desoxyguanosin-nukleotide, verfahren zu deren herstellung und deren verwendung zur nukleinsaeure-sequenzierung |
US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
CA2039517C (en) | 1990-04-03 | 2006-11-07 | David Segev | Dna probe signal amplification |
US6787338B2 (en) | 1990-06-04 | 2004-09-07 | The University Of Utah | Method for rapid thermal cycling of biological samples |
US5386023A (en) | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5484908A (en) | 1991-11-26 | 1996-01-16 | Gilead Sciences, Inc. | Oligonucleotides containing 5-propynyl pyrimidines |
DE637965T1 (de) | 1991-11-26 | 1995-12-14 | Gilead Sciences Inc | Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen. |
TW393513B (en) | 1991-11-26 | 2000-06-11 | Isis Pharmaceuticals Inc | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
US5644048A (en) | 1992-01-10 | 1997-07-01 | Isis Pharmaceuticals, Inc. | Process for preparing phosphorothioate oligonucleotides |
JPH09504785A (ja) | 1993-09-10 | 1997-05-13 | エモリー、ユニバーシティー | 抗b型肝炎ウイルス活性を有するヌクレオシド |
US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
US5972716A (en) | 1994-04-29 | 1999-10-26 | The Perkin-Elmer Corporation | Fluorescence monitoring device with textured optical tube and method for reducing background fluorescence |
US5545527A (en) | 1994-07-08 | 1996-08-13 | Visible Genetics Inc. | Method for testing for mutations in DNA from a patient sample |
US5834189A (en) | 1994-07-08 | 1998-11-10 | Visible Genetics Inc. | Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types |
US6800452B1 (en) | 1994-08-08 | 2004-10-05 | Science Applications International Corporation | Automated methods for simultaneously performing a plurality of signal-based assays |
DE69638137D1 (de) | 1995-09-07 | 2010-04-15 | Univ Georgia | Therapeutische azidverbindungen |
US6265152B1 (en) | 1995-12-22 | 2001-07-24 | Visible Genetics Inc. | Method and kit for evaluation of HIV mutations |
US6007983A (en) | 1995-12-22 | 1999-12-28 | Visible Genetics Inc. | Method and kit for evaluation of HIV mutations |
US5795722A (en) | 1997-03-18 | 1998-08-18 | Visible Genetics Inc. | Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample |
US6180777B1 (en) | 1996-01-12 | 2001-01-30 | Bayer Corporation | Synthesis of branched nucleic acids |
FR2746413B1 (fr) | 1996-03-19 | 1998-04-24 | Bio Merieux | Detection d'une sequence nucleotidique avec amplification de signal |
US6830887B2 (en) | 1997-03-18 | 2004-12-14 | Bayer Healthcare Llc | Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample |
DK0866071T3 (da) | 1997-03-20 | 2005-01-17 | Hoffmann La Roche | Modificerede primere |
JP2001514859A (ja) | 1997-09-04 | 2001-09-18 | バイエル コーポレイション | クエンチ可能な蛍光標識を有するオリゴヌクレオチドプローブおよびその使用方法 |
DE69933860T2 (de) | 1998-02-25 | 2007-05-31 | Emory University | 2'-fluoronukleoside |
ES2369818T3 (es) | 1998-11-09 | 2011-12-07 | Eiken Kagaku Kabushiki Kaisha | Procedimiento de síntesis de ácido nucleico. |
US7115584B2 (en) | 1999-01-22 | 2006-10-03 | Emory University | HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine |
US7635690B2 (en) | 1999-01-22 | 2009-12-22 | Emory University | HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine |
ATE314488T1 (de) | 1999-03-18 | 2006-01-15 | Exiqon As | Einstufige probezubereitung und bestimmung von nukleinsäure in biologischen proben |
US6734291B2 (en) | 1999-03-24 | 2004-05-11 | Exiqon A/S | Synthesis of [2.2.1]bicyclo nucleosides |
JP4768132B2 (ja) | 1999-03-24 | 2011-09-07 | エクシコン エ/エス | [2.2.1]ビシクロヌクレオシドの改良された製法 |
JP4683811B2 (ja) | 2000-05-01 | 2011-05-18 | 栄研化学株式会社 | 核酸合成反応産物の検出方法 |
EP2031058B1 (en) | 2000-09-19 | 2012-07-18 | Eiken Kagaku Kabushiki Kaisha | Method of synthesizing polynucleotide |
DE60322044D1 (de) | 2002-02-21 | 2008-08-21 | Asm Scient Inc | Rekombinase-polymerase-amplifikation |
US7399590B2 (en) | 2002-02-21 | 2008-07-15 | Asm Scientific, Inc. | Recombinase polymerase amplification |
US7662594B2 (en) | 2002-09-20 | 2010-02-16 | New England Biolabs, Inc. | Helicase-dependent amplification of RNA |
US7282328B2 (en) | 2002-09-20 | 2007-10-16 | New England Biolabs, Inc. | Helicase dependent amplification of nucleic acids |
JP4686189B2 (ja) | 2002-10-24 | 2011-05-18 | パラテック ファーマシューティカルズ インコーポレイテッド | Rnaを調節するための置換テトラサイクリン化合物の使用方法 |
ATE407939T1 (de) | 2004-06-02 | 2008-09-15 | Asm Scient Inc | 2ß-NITROBENZYL-MODIFIZIERTE RIBONUKLEOTIDE |
US7629124B2 (en) | 2006-06-30 | 2009-12-08 | Canon U.S. Life Sciences, Inc. | Real-time PCR in micro-channels |
CA2722308C (en) | 2008-04-15 | 2024-02-27 | Rfs Pharma, Llc. | Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
US9758837B2 (en) * | 2011-08-02 | 2017-09-12 | The United States Of America, As Represented By The Secretary Of Agriculture | Sensitive and rapid method for Candidatus Liberibacter species detection |
MX367192B (es) | 2013-10-30 | 2019-08-08 | Green Life Biotech Llc | Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. |
-
2014
- 2014-10-30 MX MX2016005613A patent/MX367192B/es active IP Right Grant
- 2014-10-30 JP JP2016552239A patent/JP2016538882A/ja active Pending
- 2014-10-30 US US15/142,576 patent/US10351918B2/en active Active
- 2014-10-30 WO PCT/US2014/063181 patent/WO2015066341A2/en active Application Filing
- 2014-10-30 EP EP14858493.1A patent/EP3063272A2/en not_active Withdrawn
- 2014-10-30 CN CN201480062637.1A patent/CN105722977A/zh active Pending
-
2019
- 2019-06-18 US US16/444,101 patent/US10815537B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105722977A (zh) | 2016-06-29 |
WO2015066341A3 (en) | 2015-11-12 |
US10351918B2 (en) | 2019-07-16 |
JP2016538882A (ja) | 2016-12-15 |
US10815537B2 (en) | 2020-10-27 |
MX367192B (es) | 2019-08-08 |
WO2015066341A2 (en) | 2015-05-07 |
US20160319379A1 (en) | 2016-11-03 |
EP3063272A2 (en) | 2016-09-07 |
US20190300971A1 (en) | 2019-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016005613A (es) | Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. | |
WO2014149134A3 (en) | Systems and methods to detect rare mutations and copy number variation | |
WO2014151006A3 (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
MX367963B (es) | Métodos para detectar mutaciones raras y variación en el número de copias. | |
WO2012135844A3 (en) | Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers | |
CA2941917C (en) | Methods for the diagnosis and treatment of inflammatory bowel disease | |
MX2015005015A (es) | Inhibidores heteroarilo de pde4. | |
WO2013008102A3 (en) | Methods and compositions for evaluating and/or treating chronic immune diseases | |
MX2022008523A (es) | Compuestos que interactuan con glicanos y metodos de uso. | |
EA201491339A1 (ru) | Замещенные аннеллированные пиримидины и триазины и их применение | |
EA201490546A1 (ru) | Замещенные аннелированные пиримидины и их применение | |
MX2014011500A (es) | Diagnosticos y tratamientos relacionados a inhibidores her3. | |
MX2015000863A (es) | Anticuerpos anti-siglec-15. | |
EP3394032A4 (en) | COMPOUNDS AND METHODS OF TREATMENT, DETECTION AND IDENTIFICATION OF COMPOUNDS FOR THE TREATMENT OF PARASITIC ILLNESSES BY APICOMPLEXA | |
EP2723866A4 (en) | METHOD FOR THE PROGNOSIS AND / OR DIAGNOSIS OF NEURODEEGENERATIVE DISEASES, METHOD FOR IDENTIFYING COMPOUND CANDIDATES AND COMPOUNDS FOR THE TREATMENT OF NEURODEGENATIVE DISEASES | |
WO2014028862A9 (en) | Use of dna in circulating exosomes as a diagnostic marker for metastasic disease | |
MX2018001831A (es) | Biomarcadores para el tratamiento de alopecia areata. | |
TR201909951T4 (tr) | Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem. | |
WO2012012278A3 (en) | Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex | |
WO2014197835A3 (en) | Methods and compositions for the treatment of cancer | |
MX2015011359A (es) | Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2). | |
MX2015012526A (es) | Inhibodores macrociclicos de cinasa rip2. | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
CA2888908A1 (en) | Antibodies against kidney associated antigen 1 and antigen binding fragments thereof | |
WO2013052108A3 (en) | Methods and compositions for the treatment and diagnosis of ovarian cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |